CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis is a devastating fibrotic diffuse parenchymal lung disorder that remains refractory to pharmacological therapies. Therefore, novel treatments are urgently required. CCAAT/enhancer binding protein delta (C/EBPδ) is a transcription factor that mediates critica...

Descripción completa

Detalles Bibliográficos
Autores principales: JanWillem, Duitman, Lin, Cong, Moog, Sophie, Jaillet, Madeleine, Castier, Yves, Cazes, Aurélie, Borensztajn, Keren S., Crestani, Bruno, Spek, C. Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2018
Materias:
Special Issue Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412614/
https://www.ncbi.nlm.nih.gov/pubmed/30873483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412614/
https://www.ncbi.nlm.nih.gov/pubmed/30873483

Ejemplares similares